Xcell Therapeutics (엑셀 세라퓨틱스)
The best solution provider for better cell therapy.
The best solution provider for better cell therapy.
Xcell Therapeutics, operating in the biotechnology and healthcare industries, aspires to be the premier solution provider for advanced cell therapy. Founded in 2015 in South Korea, the firm envisions a future where researchers can develop groundbreaking treatments to cure diseases, promote good health, and reduce animal suffering in research. Its serum-free, chemically defined media is meticulously crafted to enhance research outcomes and optimize manufacturing consistency, facilitating advancements in bioengineering and life sciences. The company's dedication to precision has attracted notable attention, with a Venture Round investment on 01 January 2017 secured from HB Investment and Dadam Investment. Xcell Therapeutics stands at the forefront of the transformative convergence of science and compassion.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 2 |
|
01 Jan 2017 |
No recent news or press coverage available for Xcell Therapeutics (엑셀 세라퓨틱스).
We care about your data, and we'd love to use cookies make your experience better.
